Format

Send to

Choose Destination
Circ Cardiovasc Genet. 2017 Aug;10(4). pii: e001874. doi: 10.1161/CIRCGENETICS.117.001874.

CKing Precision in the Interpretation of Diagnostic Biomarkers.

Author information

1
From the Research Center, Montreal Heart Institute, Montreal, Quebec, Canada (S.d.D., J.-C.T., M.-P.D.); Université de Montréal Beaulieu-Saucier Pharmacogenomics Center, Montreal, Quebec, Canada (S.d.D., J.-C.T., M.-P.D.); and Faculties of Pharmacy (S.d.D.) and Medicine (J.-C.T., M.-P.D.), Université de Montréal, Montreal, Quebec, Canada. simon.dedenus@icm-mhi.org.
2
From the Research Center, Montreal Heart Institute, Montreal, Quebec, Canada (S.d.D., J.-C.T., M.-P.D.); Université de Montréal Beaulieu-Saucier Pharmacogenomics Center, Montreal, Quebec, Canada (S.d.D., J.-C.T., M.-P.D.); and Faculties of Pharmacy (S.d.D.) and Medicine (J.-C.T., M.-P.D.), Université de Montréal, Montreal, Quebec, Canada.

KEYWORDS:

Editorials; biomarkers; creatine kinase; pharmacogenetics; precision medicine

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center